IGF1 and sarcopenia: Indeed, impaired action of insulin/IGF-1 signaling is counted among the potential mechanisms underlying the development of sarcopenia, a major phenomenon associated with aging, which is characterized by decreased mass and impaired function of skeletal muscle3–6.